Literature DB >> 8476531

Ultrastructural study of moniliformin induced lesions of myocardium in rats and mice.

D Zhao1, Q Feng, X Yan, C Li, Y Pan, Q Cui.   

Abstract

Effects of moniliformin on the ultrastructure of the myocardium of mice and rats were studied. Mice were given moniliformin orally at a dose of 29.46 mg.kg-1 the LD50. One h after dosing, lesions of the mitochondria of the myocardial cells were found which became more severe in 2 and 3 h. Ultrastructural lesions were also observed in the myofibrils and sarcolemma. Rats were given moniliformin orally at the dosage of 6 mg.kg-1 once daily for 56 d. Lesions of mitochondria and myofibrils were relatively mild. In the myocardiac specimens taken from the 21d post-toxin administration, lesions of the sarcolemma became more obvious. These moniliformin-induced lesions were similar to the ultrastructural changes in the myocardium of patients with Keshan disease. Our findings indicate that there may be a close and important relationship between moniliformin intoxication and Keshan disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476531

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  4 in total

1.  Development of an L6 myoblast in vitro model of moniliformin toxicosis.

Authors:  R Reams; H L Thacker; M Novilla; D Laska; J Horn; D Harrington; W Greenlee; R Vesonder
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

2.  Purified moniliformin does not affect the force or rate of contraction of isolated guinea pig atria.

Authors:  R Y Reams; H L Thacker; D D Harrington; M N Novilla; B Wilson
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

3.  Comparative cytotoxicity of fumonisin B1 and moniliformin in chicken primary cell cultures.

Authors:  W Wu; T Liu; R F Vesonder
Journal:  Mycopathologia       Date:  1995-11       Impact factor: 2.574

4.  The Sfp-type 4'-phosphopantetheinyl transferase Ppt1 of Fusarium fujikuroi controls development, secondary metabolism and pathogenicity.

Authors:  Philipp Wiemann; Sabine Albermann; Eva-Maria Niehaus; Lena Studt; Katharina W von Bargen; Nelson L Brock; Hans-Ulrich Humpf; Jeroen S Dickschat; Bettina Tudzynski
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.